About Inozyme Pharma (INZY)
Inozyme Pharma, Inc. is a rare disease biopharmaceutical company. The Company is focused on developing therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. It is focused on develop... Read more
- USD3.95
- USD3.96
- USD3.94
- USD6.24
- 310.70%
- --
- 49.88M
- 3.92M
- 74M
- 0.72
- -16.50%
Stock News
8 hours ago
Quantum Computing: Minor Q1 Results, A Slow Mover
SeekingAlpha
yesterday
Quinta Brunson isn't surprised by her success: 'I made every single move in my life so that this could happen to me'
CNBC
yesterday
Welcome to the real world, class of 2025. Here are 5 money tips you haven’t heard a million times.
MarketWatch
yesterday
Regions Financial: Preferred Shares Offer An Attractive Risk/Reward Ratio
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
